The global Electroceuticals/Bioelectric Medicine market gathered revenue around USD 15.2 Billion in 2020 and market is set to grow USD 23.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.0% during the prediction period 2021 to 2027. Market growth is driven by the rising government support & funding for neurological disorders, rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders, and the increasing investments and funding for research on CRM devices.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Electroceuticals/Bioelectric Medicine market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Electroceuticals/Bioelectric Medicine market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Electroceuticals/Bioelectric Medicine market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America is the largest regional market for electroceuticals
The global electroceuticals market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global electroceuticals market. The North American electroceuticals market's growth can be attributed to the highly developed healthcare system in the US and Canada, increasing healthcare spending, and the increasing prevalence of cardiovascular & neurological disorders.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Electroceuticals/Bioelectric Medicine Market are:
Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), LivaNova PLC (UK), Cochlear Ltd. (Australia), MicroPort Scientific Corporation (China), Sonova Group (Switzerland), Nevro Corp. (US), Axonics Modulation Technologies, Inc. (US), Neuronetics, Inc. (US), Second Sight Medical Products, Inc. (US), NeuroPace, Inc. (US), BIOTRONIK (Germany), Medico S.p.A. (Italy), Nurotron Biotechnology Co. Ltd. (US), MED-EL (Austria), Aleva Neurotherapeutics SA (Switzerland), NeuroSigma, Inc. (US), BioWave Corporation (US), Soterix Medical Inc. (US), Bioinduction Ltd. (UK), GiMer Medical (Taiwan), Cefaly (Belgium), BioControl Medical (Israel), and tVNS Technologies GmbH (Germany).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
This report categorizes the electroceuticals market into the following segments and subsegments:
By Product
By Type
By End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits For Stakeholders
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Electroceuticals/Bioelectric Medicine Market, By Product
7.1. Electroceuticals/Bioelectric Medicine Market, By Product, 2021-2027
7.1.1. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Spinal Cord Stimulators
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Cochlear Implants
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Deep Brain Stimulators
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Sacral Nerve Stimulators & Gastric Electrical Stimulators
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Transcutaneous Electrical Nerve Stimulators
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Vagus Nerve Stimulators
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Other Electrical Stimulators
7.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Electroceuticals/Bioelectric Medicine Market, By Type
8.1. Electroceuticals/Bioelectric Medicine Market, By Type, 2021-2027
8.1.1. Implantable Electroceutical Devices
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Implantable Electroceutical Devices
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Electroceuticals/Bioelectric Medicine Market, By End User
9.1. Electroceuticals/Bioelectric Medicine Market, by End User, 2021-2027
9.1.1. Hospitals, Clinics, and ASCs
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Other End Users
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Electroceuticals/Bioelectric Medicine Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.2. Market Revenue and Forecast, By Type (2016-2027)
10.1.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, By Type (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, By Type (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, By Type (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, By Type (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, By Type (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2027)
Chapter 11. Company Profiles
11.1. Medtronic plc (Ireland)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Boston Scientific Corporation (US)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Abbott Laboratories, Inc. (US)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. LivaNova PLC (UK)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cochlear Ltd. (Australia)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cochlear Ltd. (Australia)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Sonova Group (Switzerland)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Nevro Corp. (US)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Axonics Modulation Technologies, Inc. (US)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Neuronetics, Inc. (US)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms